Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyosides (encapsulated bacteria).

A A Lindberg

    Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
    |January 26, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Bacterial capsular polysaccharides are poor vaccines, especially for infants. Conjugating them to carrier proteins creates effective glycoconjugate vaccines, virtually eliminating Hib disease and showing promise for other bacterial infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity.

    Vaccine·2000
    Same author

    Vaccination against enteric pathogens: from science to vaccine trials.

    Current opinion in microbiology·1999
    Same author

    Shigella flexneri type-specific antigen V: cloning, sequencing and characterization of the glucosyl transferase gene of temperate bacteriophage SfV.

    Gene·1997
    Same author

    Molecular characterization of the genes involved in O-antigen modification, attachment, integration and excision in Shigella flexneri bacteriophage SfV.

    Gene·1997
    Same author

    Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

    Infection and immunity·1997
    Same author

    Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates.

    Microbial pathogenesis·1997
    Same journal

    [Risk of accidents for a Parisian pedestrian].

    Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie·2002
    Same journal

    Differences in the social context of song production in captive male and female European starlings.

    Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie·2002
    Same journal

    [Predictive value of biological species for plant conservation in the Mediterranean area].

    Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie·2002
    Same journal

    [Biological quality of seawater evaluated in situ with embryo-larval test of Crassostrea gigas and Mytilus galloprovincialis].

    Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie·2002
    Same journal

    Removal of cell-bound lipoproteins: a crucial step for the efficient infection of liver cells with hepatitis C virus in vitro.

    Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie·2002
    Same journal

    [Contribution of experimental models to the understanding of immunity to schistosomiasis].

    Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie·2002
    See all related articles

    Area of Science:

    • Microbiology
    • Immunology
    • Vaccinology

    Background:

    • Bacterial polysaccharide capsules are key virulence factors, protecting against phagocytosis.
    • Antibodies and complement aid opsonization, but purified capsular polysaccharides are poorly immunogenic, especially in infants.
    • This limits their use as vaccines against invasive bacterial infections.

    Purpose of the Study:

    • To review the development and success of bacterial glycoconjugate vaccines.
    • To highlight the advantages of glycoconjugates over purified polysaccharides.
    • To discuss the potential of glycoconjugate vaccines for controlling invasive bacterial diseases.

    Main Methods:

    • Review of scientific literature on bacterial capsules, immune responses, and vaccine development.

    Related Experiment Videos

  • Analysis of the efficacy of Haemophilus influenzae type b (Hib) glycoconjugate vaccines.
  • Assessment of the status of pneumococcal, meningococcal, and Salmonella typhi glycoconjugate vaccines.

    • Main Results:

    • Hib glycoconjugate vaccines have dramatically reduced invasive Hib disease incidence.
    • Glycoconjugate vaccines elicit T-dependent immune responses, including in infants, and prime for immunological memory.
    • Pneumococcal, meningococcal, and S. typhi glycoconjugate vaccines are in advanced development.

    Conclusions:

    • Covalent linkage of polysaccharides to carrier proteins creates effective T-dependent glycoconjugate vaccines.
    • Glycoconjugate vaccines offer a promising strategy for controlling and potentially eliminating invasive bacterial diseases.
    • Further development and global implementation of these vaccines are crucial.